TDAC$10.820.28%-0.03
Translational Development Acquisition Corp (TDAC)
Date: 2026-10-30 16:00O: 10.82H: 10.84L: 10.81C: 10.82Vol: 18.04k
Schlusskurs vom Vortag:
$10.85
Offen:
$10.82
24-Stunden-Volumen:
18,039
Relatives Volumen:
2.65
Marktkapitalisierung:
$208.92M
Einnahmen:
-
Nettoeinkommen (Verlust:
$6.21M
KGV:
38.17
EPS:
$0.2835
Netto-Cashflow:
-$682.00K
1W Leistung:
+0.09%
1M Leistung:
-0.09%
6M Leistung:
+1.79%
1Y Leistung:
+3.54%
1-Tages-Spanne:
$10.81$10.84
1-Wochen-Bereich:
$10.81$10.86
52-Wochen-Spanne:
$10.09$10.95
Translational Development Acquisition Corp Aktie (TDAC) Unternehmensprofil
Firmenname
Translational Development Acquisition CorpSektor
FinancialBranche
Shell CompaniesTelefon
(413) 204-2769Adresse
52 E 83RD ST., NEW YORK, USATDAC vs. VYLR, DMII, EVAC, BCSS, CEPF vergleichen
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDAC Translational Development Acquisition Corp | $10.82 | $208.92M | $0 | $6.21M | -$682.00K | $0.2835 |
 VYLR Vylor Inc. | $72.40 | $48.31B | $0 | $0 | $0 | $0.00 |
 DMII Drugs Made In America Acquisition Ii Corp | $10.20 | $649.74M | $0 | $8.58M | -$1.11M | $0.134 |
 EVAC Eqv Ventures Acquisition Corp Ii | $10.36 | $605.52M | $0 | $12.80M | -$714.00K | $0.2184 |
 BCSS Bain Capital Gss Investment Corp | $10.24 | $597.72M | $0 | $8.29M | -$686.50K | $0.142 |
 CEPF Cantor Equity Partners Iv Inc | $10.32 | $589.79M | $0 | $10.29M | -$337.90K | $0.1801 |
Translational Development Acquisition Corp Aktie (TDAC) Hochstufungen & Herabstufungen
Finanzdaten der Translational Development Acquisition Corp-Aktie (TDAC)
Umsatz
Diagramm wird aktualisiert
Dieses Diagramm ist bald wieder verfügbar.
